ClinicalTrials.gg
Not yet recruitingNCT07881614Updated Oct 19, 2026

Technology Use, Safe Health Information, and Artificial Intelligence Among Older Adults

An interventional study of E-Health Literacy Based Education in Older Adults, Nursing Homes and Artifical Intelligence, sponsored by Ondokuz Mayıs University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Ondokuz Mayıs University · Not applicable, Interventional, and Other

Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Objective The aim of this research is to evaluate how improving the technology use skills of older adults in nursing homes changes their perceptions of access to safe health information and the use of artificial intelligence.

Hypotheses H1: Improving the technology use skills of older adults in nursing homes changes their perceptions of access to safe health information and the use of artificial intelligence.

Read the detailed description

The rapid increase in the older population worldwide and in our country necessitates new approaches to accessing healthcare services. With the impact of digitalization on healthcare, e-health applications (online appointment systems, telehealth services, electronic health records, etc.) have become widespread; however, the ability of older adults to effectively use these systems largely depends on their e-health literacy levels. Older adults in nursing homes, in particular, require more support in accessing healthcare services due to both physical and social limitations, and stand out as a disadvantaged group in adapting to digital technologies. This situation makes it crucial to improve the technology usage skills of older adults, thereby changing their perceptions regarding access to reliable health information and the use of artificial intelligence.

02

Conditions studied

  • Older Adults
  • Nursing Homes
  • Artifical Intelligence
  • Technology Use
  • Health

Keywords

  • Older Adult
  • Artifical Intelligence
  • Technology
  • Nursing Home
  • Health
03

In context

Lead sponsor

Ondokuz Mayıs University is the lead sponsor of 272 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years or older
  • Residing in a nursing home
  • Being literate
  • Having no visual or hearing impairment that would interfere with the training
  • Being willing to communicate and cooperate
  • Having a smartphone and access to the internet
  • Voluntarily agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

-A score below 24 on the Standardized Mini-Mental State Examination and having a serious psychiatric disorder (e.g., dementia or schizophrenia) that would prevent participation in the study

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    In the study, older adults in the experimental group will receive e-health literacy-based education once a week for 6 weeks, for a total of 6 sessions.

    Other: E-Health Literacy Based Education

  • No intervention
    Control Group

    Individuals in the control group will not participate in the intervention. Individuals in control group will continue their routine activities in nursing home.

Interventions

  • OtherE-Health Literacy Based Education

    Older adults in the experimental group will participate in education sessions based on the E-Health Literacy Model.

06

What researchers measure

Primary outcomes

  1. Standardized Mini Mental State Examination

    Standardized Mini Mental State Examination was developed by Folstein et al. (1975) to be used in dementia screening and adapted into Turkish by Güngen et al. (2002) to assess cognitive status. This scale is examined under five main headings and evaluated as recording memory (3 points), orientation (10 points), recall (3 points), attention and calculation (5 points) and language (9 points). There are two separate forms of the Mini Mental State for educated and uneducated individuals. The scale is evaluated out of 30 points; 24-30 is considered as normal, below 24 as cognitive impairment, 18-23 as mild dementia, 12-17 as moderate dementia and below 12 as severe dementia.

    Time frame: The scale will be applied at baseline, pre-intervention.

  2. E-Health Literacy Scale

    The E-Health Literacy Scale was developed by Norman and Skinner (2006a) and its Turkish validity and reliability study was conducted by Uskun et al. (2022). In the Turkish adaptation, the Cronbach Alpha internal consistency coefficient was calculated as 0.97. The scale consists of 2 items related to internet use and 8 items measuring internet attitudes. The scale items were designed using a 5-point Likert scale method. The lowest possible score on the scale is 8, and the highest possible score is 40.

    Time frame: This scale will be applied at baseline and after the 6 weeks experiment.

07

Study locations

1 site
  • Ordu University
    Ordu, Altınordu 52200, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07881614
Responsible party
Murselcan Kabakcı (Specialist Nurse (PhD.), Ondokuz Mayıs University) — Principal investigator
First posted
Oct 19, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Mar 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

Mürselcan Kabakcı, PhD.
Contact
murselcan28@gmail.com
537 561 5067

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion